Novo Nordisk submits diabetes pill for U.S. approval

Novo Nordisk has submitted its oral semaglutide drug, a pill it hopes will transform the diabetes market, for approval in the United States.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news